Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Linus Backert, Daniel J. Kowalewski, Simon D. Walz, Heiko Schuster, Claudia Berlin, Mirle Schemionek, PhD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Lothar Kanz, MD, Helmut R. Salih, MD, Katja Weisel, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 2169.

https://doi.org/10.1182/blood.V128.22.2169.2169

Published: 2016

Journal Articles

Unique Alterations in the Immunopeptidome of Colorectal Cancer Reflect Specific Transformations in Cancer-Associated Signaling Pathways and Reveal Tumor-Specific HLA-Ligand Modulations

Sebastian P. Haen, MD, Daniel J. Kowalewski, Joerg Bernhardt, Linus Backert, Daniel Backes, Florian Dengler, Stefan Beckert, Ingmar Koenigsrainer, Hans-Georg Kopp, MD, Oliver Kohlbacher, Alfred Koenigsrainer, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Markus W. Loeffler, MD

Blood (2016) 128 (22): 862.

https://doi.org/10.1182/blood.V128.22.862.862

Published: 2016

Journal Articles

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy

Annika Nelde, Daniel J. Kowalewski, Linus Backert, Heiko Schuster, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 3234.

https://doi.org/10.1182/blood.V128.22.3234.3234

Published: 2016

Journal Articles

ROR1 Specific T Cell Clones from Healthy Individuals Show Common T Cell Receptor Motifs

Falk Heidenreich, PhD, Elke Ruecker-Braun, PhD, Juliane S. Stickel, MD, Anne Eugster, PhD, Denise Kühn, BSc, Sevina Dietz, Annika Nelde, Antje Tunger, MSc, Rebekka Wehner, PhD, Jan Moritz Middeke, MD, Cornelia S Link, MD, Friedrich Stölzel, MD, Stefan Stevanovic, PhD, Ezio Bonifacio, PhD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Marc Schmitz, PhD, Johannes Schetelig, MD MSc

Blood (2016) 128 (22): 3364.

https://doi.org/10.1182/blood.V128.22.3364.3364

Published: 2016

Journal Articles

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia Identifies Novel CD8 + and CD4 + T Cell-Epitopes for Immunotherapeutic Approaches

Tatjana Bilich, Annika Nelde, Daniel J. Kowalewski, Janet Peper, Mirle Schemionek, PhD, Lothar Kanz, MD, Helmut R. Salih, MD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 4232.

https://doi.org/10.1182/blood.V128.22.4232.4232

Published: 2016

Journal Articles

Identification of Naturally Presented HLA Ligands of Enriched Leukemic Progenitor Cells for Peptide-Based Immunotherapy in Acute Myeloid Leukemia (AML)

Annika Nelde, Heiko Schuster, Daniel J. Kowalewski, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 4046.

https://doi.org/10.1182/blood.V128.22.4046.4046

Published: 2016

Journal Articles

Interplay Between the Immune System and Colorectal Carcinoma - Towards Tumor-Specific Peptide-Based Vaccination for Any HLA-Type

Sebastian P. Haen, MD, Daniel Johannes Kowalewski, Stefan Stevanovic, PhD, Linus Backert, Florian Dengler, Daniel Backes, Stefan Beckert, Wagner Silvia, Ingmar Koenigsrainer, Hans-Georg Kopp, MD, Oliver Kohlbacher, Alfred Koenigsrainer, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Markus W. Loeffler, MD

Blood (2015) 126 (23): 1027.

https://doi.org/10.1182/blood.V126.23.1027.1027

Published: 2015

Journal Articles

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

Pamela Stein, PhD, Karsten Gogoll, PhD, Tanja Peters, PhD, Mark Denny, Stefan Tenzer, PhD, Stefan Stevanovic, PhD, Hansjoerg Schild, PhD Prof., Matthias Theobald, MD PhD, Peter Langguth, Markus Radsak, MD

Blood (2015) 126 (23): 2224.

https://doi.org/10.1182/blood.V126.23.2224.2224

Published: 2015

Journal Articles

Identification and Characterization of HLA Class I-Restricted MYD88 L265P-Derived Peptides As Tumor-Specific Targets for Immunotherapy

Annika Nelde, Juliane S Stickel, MD, Daniel Johannes Kowalewski, Oliver Olaf Wolz, Lothar Kanz, MD, Anton W. Langerak, Alice F. Muggen, Irina Bonzheim, Falko Fend, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Alexander N.R. Weber

Blood (2015) 126 (23): 2750.

https://doi.org/10.1182/blood.V126.23.2750.2750

Published: 2015

Journal Articles

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Secondary Skin Cancers

Juliane S Stickel, MD, Daniel Johannes Kowalewski, Heiko Schuster, Stefan Kahn, Linus Backert, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD

Blood (2015) 126 (23): 1722.

https://doi.org/10.1182/blood.V126.23.1722.1722

Published: 2015

Journal Articles

Mapping the Impact of Proteasome Inhibitor Therapy on the Immunopeptidome of Multiple Myeloma: Mass Spectrometry Identifies Robust Targets for T Cell Immunotherapy

Daniel Johannes Kowalewski, Simon D. Walz, Linus Backert, Heiko Schuster, Susanne M. Rittig, MD, Katja C. Weisel, Helmut R Salih, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S Stickel, MD

Blood (2015) 126 (23): 3001.

https://doi.org/10.1182/blood.V126.23.3001.3001

Published: 2015

Journal Articles

HLA Ligandome Profiling Identifies a Novel Category of Pathophysiologically Relevant CLL Associated Antigens

Daniel J. Kowalewski, Heiko Schuster, Claudia Berlin, Stefan Kahn, Linus Backert, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2014) 124 (21): 715.

https://doi.org/10.1182/blood.V124.21.715.715

Published: 2014

Journal Articles

HLA Ligandome Analysis in Multiple Myeloma Reveals Novel Naturally Presented Myeloma-Associated Antigens Showing Stable Expression Under Proteasome Inhibitor Therapy

Simon D. Walz, Daniel J. Kowalewski, Heiko Schuster, Katja Weisel, MD, Helmut R. Salih, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2014) 124 (21): 3438.

https://doi.org/10.1182/blood.V124.21.3438.3438

Published: 2014

Journal Articles

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia (CML)—Towards Peptide Based Immunotherapy

Daniel J. Kowalewski, Mirle Schemionek, Lothar Kanz, MD, Helmut R. Salih, MD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2014) 124 (21): 4518.

https://doi.org/10.1182/blood.V124.21.4518.4518

Published: 2014

Journal Articles

HLA Ligandome Analysis in Primary Polycythemia Vera (PV) Samples Shows No Tumor-Association of Naturally Presented JAK2 Ligands but Reveals a Vast Array of Novel PV-Associated HLA Ligands

Juliane S. Stickel, MD, Daniel J. Kowalewski, Steffen Koschmieder, MD, Lothar Kanz, MD, Helmut R. Salih, MD, Tim H. Brümmendorf, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD

Blood (2014) 124 (21): 4581.

https://doi.org/10.1182/blood.V124.21.4581.4581

Published: 2014

Journal Articles

Identification of Novel Tumor-Associated Antigens for Chronic Lymphocytic Leukemia (CLL) Based On HLA Ligandome Analysis – New Targets for Peptide Based Immunotherapy

Daniel Johannes Kowalewski, Heiko Schuster, Claudia Berlin, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, Prof., Stefan Stevanovic, PhD, Juliane Sarah Stickel, MD

Blood (2012) 120 (21): 4119.

https://doi.org/10.1182/blood.V120.21.4119.4119

Published: 2012

Journal Articles

Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner

Shigeo Fuji, Julia Fischer, Markus Kapp, Thomas G Bumm, MD, Hermann Einsele, Stefan Stevanovic, PhD, Hans-Georg Rammensee, Prof., Thomas Hunig, Götz Ulrich Grigoleit, MD

Blood (2012) 120 (21): 4351.

https://doi.org/10.1182/blood.V120.21.4351.4351

Published: 2012

Journal Articles

HLA Ligandome Analysis of Acute Myeloid Leukemia (AML) Revealed Novel Tumor-Associated Antigens for Immunotherapy.

Juliane Sarah Stickel, MD, Claudia Berlin, Daniel Johannes Kowalewski, Heiko Schuster, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, Prof., Stefan Stevanovic, PhD

Blood (2012) 120 (21): 3012.

https://doi.org/10.1182/blood.V120.21.3012.3012

Published: 2012

Journal Articles

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

Cristina N. Boß, Frank Grünebach, PhD, Katharina M. Brauer, Toni Weinschenk, PhD, Lothar Kanz, MD, Stefan Stevanovic, PhD, Hans-Georg Rammensee, PhD, Peter Brossart, MD

Blood (2006) 108 (11): 3703.

https://doi.org/10.1182/blood.V108.11.3703.3703

Published: 2006

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Unique Alterations in the Immunopeptidome of Colorectal Cancer Reflect Specific Transformations in Cancer-Associated Signaling Pathways and Reveal Tumor-Specific HLA-Ligand Modulations

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy

ROR1 Specific T Cell Clones from Healthy Individuals Show Common T Cell Receptor Motifs

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia Identifies Novel CD8 + and CD4 + T Cell-Epitopes for Immunotherapeutic Approaches

Identification of Naturally Presented HLA Ligands of Enriched Leukemic Progenitor Cells for Peptide-Based Immunotherapy in Acute Myeloid Leukemia (AML)

Interplay Between the Immune System and Colorectal Carcinoma - Towards Tumor-Specific Peptide-Based Vaccination for Any HLA-Type

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

Identification and Characterization of HLA Class I-Restricted MYD88 L265P-Derived Peptides As Tumor-Specific Targets for Immunotherapy

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Secondary Skin Cancers

Mapping the Impact of Proteasome Inhibitor Therapy on the Immunopeptidome of Multiple Myeloma: Mass Spectrometry Identifies Robust Targets for T Cell Immunotherapy

HLA Ligandome Profiling Identifies a Novel Category of Pathophysiologically Relevant CLL Associated Antigens

HLA Ligandome Analysis in Multiple Myeloma Reveals Novel Naturally Presented Myeloma-Associated Antigens Showing Stable Expression Under Proteasome Inhibitor Therapy

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia (CML)—Towards Peptide Based Immunotherapy

HLA Ligandome Analysis in Primary Polycythemia Vera (PV) Samples Shows No Tumor-Association of Naturally Presented JAK2 Ligands but Reveals a Vast Array of Novel PV-Associated HLA Ligands

Identification of Novel Tumor-Associated Antigens for Chronic Lymphocytic Leukemia (CLL) Based On HLA Ligandome Analysis – New Targets for Peptide Based Immunotherapy

Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner

HLA Ligandome Analysis of Acute Myeloid Leukemia (AML) Revealed Novel Tumor-Associated Antigens for Immunotherapy.

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only